Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment

Combined vaccines containing non-cellular pertussis component and having low reactogenicity, increase vaccination coverage against controllable infections. However, the safety of vaccination in children dealing with health issues, as well as those having a history of premature infancy, requires addi...

Full description

Saved in:
Bibliographic Details
Main Authors: D. А. Novikova, L. S. Namazova-Baranova, А. G. Gayvoronskaya, М. I. Broeva, М. V. Fedoseenko
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2015-08-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/704
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690710071050240
author D. А. Novikova
L. S. Namazova-Baranova
А. G. Gayvoronskaya
М. I. Broeva
М. V. Fedoseenko
author_facet D. А. Novikova
L. S. Namazova-Baranova
А. G. Gayvoronskaya
М. I. Broeva
М. V. Fedoseenko
author_sort D. А. Novikova
collection DOAJ
description Combined vaccines containing non-cellular pertussis component and having low reactogenicity, increase vaccination coverage against controllable infections. However, the safety of vaccination in children dealing with health issues, as well as those having a history of premature infancy, requires additional research. The article presents reactogenicity analysis for the DTP-IPV/HIB pentavaccine during primary vaccination and revaccination of premature infants (n = 85), as well as vaccination of mature newborns (n = 1433) inoculated in accordance with the national Vaccination Calendar behind the schedule. The occurrence of post-vaccinal reactions in the premature infant group was the same as in the mature infant group and amounted to 41.2% and 45.0%; the occurrence of common reactions was 18.8% and 22.4%; local effects measured 25.8% and 27.9% respectively. Post-vaccinal reactions were either weak or moderate, not requiring treatment, and they would completely disappear by the end of the third post-vaccinal day. Simultaneous injection of pentavaccine and Hepatitis B vaccine and pneumococcal conjugate vaccine in children with a history of premature infancy, showed no influence during the post-vaccinal period. The reactogenicity of pentavaccine increased along with the vaccination ratio during the primary series of vaccinations.
format Article
id doaj-art-4f27549a03874a2bb3c8afd88961eb5b
institution DOAJ
issn 1682-5527
1682-5535
language English
publishDate 2015-08-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj-art-4f27549a03874a2bb3c8afd88961eb5b2025-08-20T03:21:14Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352015-08-0114339239510.15690/vsp.v14i3.1376704Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s ExperimentD. А. Novikova0L. S. Namazova-Baranova1А. G. Gayvoronskaya2М. I. Broeva3М. V. Fedoseenko4Scientific Centre of Children Health, Moscow, Russian FederationScientific Centre of Children Health, Moscow, Russian Federation I.M. Sechenov First Moscow State Medical University, Russian Federation Pirogov Russian National Research Medical University, Moscow, Russian FederationScientific Centre of Children Health, Moscow, Russian FederationScientific Centre of Children Health, Moscow, Russian FederationScientific Centre of Children Health, Moscow, Russian FederationCombined vaccines containing non-cellular pertussis component and having low reactogenicity, increase vaccination coverage against controllable infections. However, the safety of vaccination in children dealing with health issues, as well as those having a history of premature infancy, requires additional research. The article presents reactogenicity analysis for the DTP-IPV/HIB pentavaccine during primary vaccination and revaccination of premature infants (n = 85), as well as vaccination of mature newborns (n = 1433) inoculated in accordance with the national Vaccination Calendar behind the schedule. The occurrence of post-vaccinal reactions in the premature infant group was the same as in the mature infant group and amounted to 41.2% and 45.0%; the occurrence of common reactions was 18.8% and 22.4%; local effects measured 25.8% and 27.9% respectively. Post-vaccinal reactions were either weak or moderate, not requiring treatment, and they would completely disappear by the end of the third post-vaccinal day. Simultaneous injection of pentavaccine and Hepatitis B vaccine and pneumococcal conjugate vaccine in children with a history of premature infancy, showed no influence during the post-vaccinal period. The reactogenicity of pentavaccine increased along with the vaccination ratio during the primary series of vaccinations.https://vsp.spr-journal.ru/jour/article/view/704premature infantsvaccinationreactogenicitypentavaccinepertussisdiphtheriatetanuspoliomyelitishaemophilus influenzae type b
spellingShingle D. А. Novikova
L. S. Namazova-Baranova
А. G. Gayvoronskaya
М. I. Broeva
М. V. Fedoseenko
Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment
Вопросы современной педиатрии
premature infants
vaccination
reactogenicity
pentavaccine
pertussis
diphtheria
tetanus
poliomyelitis
haemophilus influenzae type b
title Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment
title_full Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment
title_fullStr Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment
title_full_unstemmed Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment
title_short Safety Analysis for Pentavaccine Used in Premature Infants: Family Vaccination Centre’s Experiment
title_sort safety analysis for pentavaccine used in premature infants family vaccination centre s experiment
topic premature infants
vaccination
reactogenicity
pentavaccine
pertussis
diphtheria
tetanus
poliomyelitis
haemophilus influenzae type b
url https://vsp.spr-journal.ru/jour/article/view/704
work_keys_str_mv AT danovikova safetyanalysisforpentavaccineusedinprematureinfantsfamilyvaccinationcentresexperiment
AT lsnamazovabaranova safetyanalysisforpentavaccineusedinprematureinfantsfamilyvaccinationcentresexperiment
AT aggayvoronskaya safetyanalysisforpentavaccineusedinprematureinfantsfamilyvaccinationcentresexperiment
AT mibroeva safetyanalysisforpentavaccineusedinprematureinfantsfamilyvaccinationcentresexperiment
AT mvfedoseenko safetyanalysisforpentavaccineusedinprematureinfantsfamilyvaccinationcentresexperiment